Fresenius Medical Care AG KGaA Debt to Equity Ratio 2010-2022 | FMS

Current and historical debt to equity ratio values for Fresenius Medical Care AG KGaA (FMS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Fresenius Medical Care AG KGaA debt/equity for the three months ending September 30, 2022 was 0.48.
Fresenius Medical Care AG KGaA Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2022-09-30 $21.83B $16.86B 1.30
2022-06-30 $21.94B $16.44B 1.33
2022-03-31 $22.65B $16.32B 1.39
2021-12-31 $24.12B $16.54B 1.46
2021-09-30 $24.04B $15.86B 1.52
2021-06-30 $24.31B $15.44B 1.58
2021-03-31 $24.06B $15.91B 1.51
2020-12-31 $22.11B $14.09B 1.57
2020-09-30 $23.84B $14.80B 1.61
2020-06-30 $22.98B $14.67B 1.57
2020-03-31 $22.95B $14.64B 1.57
2019-12-31 $22.07B $14.82B 1.49
2019-09-30 $21.82B $15.06B 1.45
2019-06-30 $21.53B $14.39B 1.50
2019-03-31 $21.72B $15.02B 1.45
2018-12-31 $15.76B $15.24B 1.03
2018-09-30 $15.40B $14.36B 1.07
2018-06-30 $15.58B $14.29B 1.09
2018-03-31 $16.28B $13.41B 1.21
2017-12-31 $14.92B $12.24B 1.22
2017-09-30 $15.96B $12.54B 1.27
2017-06-30 $15.43B $11.76B 1.31
2017-03-31 $15.43B $12.04B 1.28
2016-12-31 $15.48B $11.46B 1.35
2016-09-30 $15.42B $11.24B 1.37
2016-06-30 $15.72B $10.83B 1.45
2016-03-31 $15.26B $10.81B 1.41
2015-12-31 $14.87B $10.50B 1.42
2015-09-30 $15.17B $10.24B 1.48
2015-06-30 $14.98B $10.43B 1.44
2015-03-31 $14.73B $10.38B 1.42
2014-12-31 $15.35B $10.03B 1.53
2014-09-30 $13.73B $10.52B 1.31
2014-06-30 $13.82B $10.32B 1.34
2014-03-31 $13.11B $10.31B 1.27
2013-12-31 $12.99B $10.13B 1.28
2013-09-30 $12.80B $9.74B 1.31
2013-06-30 $12.68B $9.65B 1.31
2013-03-31 $12.24B $9.90B 1.24
2012-12-31 $12.60B $9.73B 1.29
2012-09-30 $12.42B $9.44B 1.32
2012-06-30 $12.73B $9.01B 1.41
2012-03-31 $12.85B $9.14B 1.41
2011-12-31 $11.06B $8.47B 1.31
2011-09-30 $10.41B $8.22B 1.27
2011-06-30 $10.83B $8.23B 1.32
2011-03-31 $10.24B $7.88B 1.30
2010-12-31 $9.29B $7.80B 1.19
2010-09-30 $9.23B $7.47B 1.24
2010-06-30 $9.07B $6.93B 1.31
2010-03-31 $8.75B $7.13B 1.23
2009-12-31 $8.79B $7.03B 1.25
2009-09-30 $8.98B $6.71B 1.34
2009-06-30 $8.95B $6.39B 1.40
2009-03-31 $8.63B $6.24B 1.38
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.600B $20.846B
Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
STERIS (STE) Ireland $19.157B 23.84
Teleflex (TFX) United States $11.379B 18.46
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00